{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:48:13Z","timestamp":1761518893132},"reference-count":60,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Treatment Reviews"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1016\/j.ctrv.2008.08.001","type":"journal-article","created":{"date-parts":[[2008,10,6]],"date-time":"2008-10-06T04:24:48Z","timestamp":1223267088000},"page":"47-56","source":"Crossref","is-referenced-by-count":11,"title":["Treating elderly patients with hormone sensitive breast cancer: What do the data show?"],"prefix":"10.1016","volume":"35","author":[{"given":"L.","family":"Balducci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 2","key":"10.1016\/j.ctrv.2008.08.001_bib1","doi-asserted-by":"crossref","first-page":"S159","DOI":"10.1016\/j.breast.2007.07.026","article-title":"Adjuvant treatment of elderly breast cancer patients","volume":"16","author":"Muss","year":"2007","journal-title":"Breast"},{"key":"10.1016\/j.ctrv.2008.08.001_bib2","unstructured":"Ries LAG, Melbert D, Krapcho M, et al., editors. SEER cancer statistics review, 1975\u20132004. Bethesda: National Cancer Institute."},{"key":"10.1016\/j.ctrv.2008.08.001_bib3","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0140-6736(04)17666-6","article-title":"Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years\u2019 adjuvant treatment for breast cancer","volume":"365","author":"Howell","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ctrv.2008.08.001_bib4","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1056\/NEJMoa052258","article-title":"Breast International Group (BIG) 1\u201398 Collaborative Group. A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer","volume":"353","author":"Th\u00fcrlimann","year":"2005","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ctrv.2008.08.001_bib5_1","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0140-6736(07)60200-1","article-title":"Intergroup Exemestane Study Survival and safety of exemestane versus tamoxifen after 2\u20133 years\u2019 tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial","volume":"369","author":"Coombes","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ctrv.2008.08.001_bib5_2","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S0140-6736(07)60448-6","volume":"369","author":"Coombes","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ctrv.2008.08.001_bib6","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1093\/jnci\/dji250","article-title":"Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA. 17","volume":"97","author":"Goss","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ctrv.2008.08.001_bib7","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1200\/JCO.2005.09.121","article-title":"American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004","volume":"23","author":"Winer","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2008.08.001_bib8","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/nrc1675","article-title":"Cancer and ageing: a nexus at several levels","volume":"5","author":"Balducci","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ctrv.2008.08.001_bib9","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/gerona\/62.4.408","article-title":"The burden of diseases on disability-free life expectancy in later life","volume":"62","author":"Jagger","year":"2007","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.ctrv.2008.08.001_bib10","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/BF03324569","article-title":"Age- and sex-stratified prevalence of physical disabilities and handicap in the general population","volume":"16","author":"Ethgen","year":"2004","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.ctrv.2008.08.001_bib11","unstructured":"MedicineNet.com. What are the complications and effects of menopause on chronic medical conditions? <http:\/\/www.medicinenet.com\/menopause\/page4.htm> [Accessed 14.04.2008]."},{"key":"10.1016\/j.ctrv.2008.08.001_bib12","unstructured":"The Cleveland Clinic. Osteoporosis and you: protecting your bones. <http:\/\/www.webmd.com\/solutions\/osteoporosis-risks\/osteoporosis-facts> [Accessed 14.04.2008]."},{"key":"10.1016\/j.ctrv.2008.08.001_bib13","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1046\/j.1532-5415.2003.51110.x","article-title":"Estimating hip fracture morbidity, mortality and costs","volume":"51","author":"Braithwaite","year":"2003","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.ctrv.2008.08.001_bib14","unstructured":"American Heart Association. Heart disease and stroke statistics \u2013 2006 Update. Dallas: American Heart Association; 2006."},{"key":"10.1016\/j.ctrv.2008.08.001_bib15","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.295.7.801","article-title":"Development and validation of a prognostic index for 4-year mortality in older adults","volume":"295","author":"Lee","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.ctrv.2008.08.001_bib16","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0002-9343(02)01484-5","article-title":"Coagulation and activation of inflammatory pathways in the development of functional decline and mortality in the elderly","volume":"114","author":"Cohen","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/j.ctrv.2008.08.001_bib17","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1002\/cncr.22634","article-title":"Age-specific association of steroid hormone pathway gene polymorphisms with breast cancer risk","volume":"109","author":"Ralph","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.ctrv.2008.08.001_bib18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/107327480701400104","article-title":"Biology of aging and cancer","volume":"14","author":"Anisimov","year":"2007","journal-title":"Cancer Control"},{"key":"10.1016\/j.ctrv.2008.08.001_bib19","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/0-387-23962-6_4","article-title":"The influence of advanced age on cancer occurrence and growth","volume":"124","author":"Ershler","year":"2005","journal-title":"Cancer Treat Res"},{"key":"10.1016\/j.ctrv.2008.08.001_bib20","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nrm2233","article-title":"Cellular senescence: when bad things happen to good cells","volume":"8","author":"Campisi","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.ctrv.2008.08.001_bib21","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1471-0528.2007.01520.x","article-title":"Hormone replacement therapy use and variations in the risk of breast cancer","volume":"115","author":"Opatrny","year":"2008","journal-title":"BJOG"},{"key":"10.1016\/j.ctrv.2008.08.001_bib22","doi-asserted-by":"crossref","first-page":"104","DOI":"10.7326\/0003-4819-120-2-199401150-00002","article-title":"The effect of comorbidity on 3-year survival of women with primary breast cancer","volume":"120","author":"Satariano","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ctrv.2008.08.001_bib23","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/ijc.22431","article-title":"Management of early breast cancer in the elderly","volume":"120","author":"Rao","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ctrv.2008.08.001_bib24","first-page":"1507","article-title":"Cancer and aging","volume":"vol. 2","author":"Beghe","year":"2006"},{"issue":"Suppl. 1","key":"10.1016\/j.ctrv.2008.08.001_bib25","first-page":"S257","article-title":"Tumor biology of breast carcinoma in elderly women: Comparison between elderly and young postmenopausal women","volume":"100","author":"Okanami","year":"2007","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ctrv.2008.08.001_bib26","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S1040-8428(02)00144-0","article-title":"Primary breast cancer in elderly women: biological profile and relation with clinical outcome","volume":"45","author":"Daidone","year":"2003","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ctrv.2008.08.001_bib27","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1002\/cncr.21030","article-title":"Hormone receptor status and survival in a population-based cohort of patients with breast carcinoma","volume":"103","author":"Grann","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.ctrv.2008.08.001_bib28","first-page":"369","article-title":"Institut Curie Breast Cancer Study Group","volume":"13","author":"Pierga","year":"2004","journal-title":"Characteristics and outcome of 1755 operable breast cancers in women over 70 years of age. Breast"},{"key":"10.1016\/j.ctrv.2008.08.001_bib29","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1200\/JCO.2003.02.046","article-title":"Undertreatment strongly decreases prognosis of breast cancer in elderly women","volume":"21","author":"Bouchardy","year":"2003","journal-title":"J Clin Oncol"},{"issue":"18S","key":"10.1016\/j.ctrv.2008.08.001_bib30","first-page":"39s","article-title":"Tamoxifen discontinuance among women aged 65 years and older with estrogen receptor positive breast cancer","volume":"24","author":"Owusu","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2008.08.001_bib31","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1046\/j.1525-1497.2003.20724.x","article-title":"Meta-analysis of vascular and neoplastic events associated with tamoxifen","volume":"18","author":"Braithwaite","year":"2003","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.ctrv.2008.08.001_bib32","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/sj.bjc.6603600","article-title":"Surgery, with or without tamoxifen, vs tamoxifen alone for older women with operable breast cancer: Cochrane review","volume":"96","author":"Hind","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ctrv.2008.08.001_bib33","unstructured":"Arimidex\u00ae (Anastrozole) package insert. Astra Zeneca Pharmaceuticals LP: Wilmington, Delaware; 2005."},{"key":"10.1016\/j.ctrv.2008.08.001_bib34_1","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1200\/JCO.2003.09.124","article-title":"Barriers to clinical trial participation by older women with breast cancer","volume":"21","author":"Kemeny","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2008.08.001_bib34_2","first-page":"4811","article-title":"Barriers to clinical trial participation by older women with breast cancer","volume":"22","author":"Kemeny","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2008.08.001_bib35","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1056\/NEJM199912303412706","article-title":"Underrepresentation of patients 65 years of age or older in cancer-treatment trials","volume":"341","author":"Hutchins","year":"1999","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ctrv.2008.08.001_bib36","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2007.14.0459","article-title":"Letrozole compared with tamoxifen for elderly patients with endocrine-responsive early breast cancer: the BIG 1\u201398 trial","author":"Crivellari","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2008.08.001_bib37","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1200\/JCO.2000.18.8.1709","article-title":"What threshold for adjuvant therapy in older breast cancer patients?","volume":"18","author":"Extermann","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2008.08.001_bib38","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1002\/1097-0142(20001015)89:8<1739::AID-CNCR14>3.0.CO;2-F","article-title":"The effect of less than definitive care on breast carcinoma recurrence and mortality","volume":"89","author":"Lash","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.ctrv.2008.08.001_bib39","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1524-4741.2007.00444.x","article-title":"Surgery is associated with lower morbidity and longer survival in elderly breast cancer patients over 80","volume":"13","author":"Rao","year":"2007","journal-title":"Breast J"},{"key":"10.1016\/j.ctrv.2008.08.001_bib40","doi-asserted-by":"crossref","unstructured":"Early Breast Cancer Trialists\u2019 Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005;365:1687\u201317.","DOI":"10.1016\/S0140-6736(05)66544-0"},{"issue":"1","key":"10.1016\/j.ctrv.2008.08.001_bib41","first-page":"CD004272","article-title":"Surgery versus primary endocrine therapy for operable primary breast cancer in elderly women (70 years plus)","author":"Hind","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ctrv.2008.08.001_bib42","unstructured":"Words to Live By. Matria Healthcare. <http:\/\/www.cancerpage.com\/newsletter\/2006\/2006_10_20.asp>. [Accessed 14.04.2008]."},{"key":"10.1016\/j.ctrv.2008.08.001_bib43","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00228-007-0392-3","article-title":"Factors associated with changes in antidepressant use in a community-dwelling elderly cohort: the Three-City Study","volume":"64","author":"Soudry","year":"2008","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.ctrv.2008.08.001_bib44","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1093\/annonc\/mdm365","article-title":"Adjuvant treatment of early breast cancer: do the St Gallen recommendations influence clinical practice? Results from the NORA study","volume":"18","author":"Cazzaniga","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ctrv.2008.08.001_bib45","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10549-007-9558-z","article-title":"Diffusion of aromatase inhibitors for breast cancer therapy between 1996 and 2003 in the Cancer Research Network","volume":"107","author":"Aiello","year":"2008","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ctrv.2008.08.001_bib46","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2007.12.6334","article-title":"Efficacy, toxicity, and quality of life in older women with early-stage breast cancer treated with letrozole or placebo after 5 years of tamoxifen: NCIC CTG Intergroup Trial MA.17.","author":"Muss","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2008.08.001_bib47","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1470-2045(07)70385-6","article-title":"Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial","volume":"9","author":"Forbes","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctrv.2008.08.001_bib48","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1586\/14737140.7.5.627","article-title":"The Breast International Group 1\u201398 trial: big results for women with hormone-sensitive early breast cancer","volume":"7","author":"Monnier","year":"2007","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.ctrv.2008.08.001_bib49","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1056\/NEJMoa040331","article-title":"Intergroup Exemestane Study. A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer","volume":"350","author":"Coombes","year":"2004","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ctrv.2008.08.001_bib50","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1056\/NEJMoa032312","article-title":"A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer","volume":"349","author":"Goss","year":"2003","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ctrv.2008.08.001_bib51","doi-asserted-by":"crossref","first-page":"6931","DOI":"10.1200\/JCO.2005.11.181","article-title":"Assessment of quality of life in MA 17: a randomized, placebo-controlled trial of letrozole after 5 years of tamoxifen in postmenopausal women","volume":"23","author":"Whelan","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2008.08.001_bib52","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/jnci\/djn014","article-title":"Competing causes of death from a randomized trial of extended adjuvant endocrine therapy for breast cancer","volume":"100","author":"Chapman","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ctrv.2008.08.001_bib53","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1016\/j.ejca.2007.07.007","article-title":"Clinical decision making in breast cancer: TAM and aromatase inhibitors for older patients \u2013 a jungle?","volume":"43","author":"Biganzoli","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ctrv.2008.08.001_bib54","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S1470-2045(07)70378-9","article-title":"International Society of Geriatric Oncology Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology.","volume":"8","author":"Wildiers","year":"2007","journal-title":"Lancet Oncol"},{"issue":"Suppl. 9","key":"10.1016\/j.ctrv.2008.08.001_bib55","article-title":"Comparing AI cardiovascular safety data: trial comparators and outcomes","volume":"17","author":"Monnier","year":"2006","journal-title":"Ann Oncol"},{"issue":"Suppl. 1","key":"10.1016\/j.ctrv.2008.08.001_bib56","first-page":"S8","article-title":"The effect of zoledronic acid on aromatase inhibitor-associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole: the Z-FAST study 36-month follow-up","volume":"100","author":"Brufsky","year":"2007","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.ctrv.2008.08.001_bib57","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.critrevonc.2007.12.008","article-title":"Significant proportion of elderly patients develop hormone-dependant \u201cluminal-B\u201d tumors associated with aggressive characteristics","volume":"67","author":"Durbecq","year":"2008","journal-title":"Crit Rev Oncol Hematol"},{"issue":"4S","key":"10.1016\/j.ctrv.2008.08.001_bib58","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1200\/jco.2004.22.14_suppl.508","article-title":"The effect of CYP 2D6 genotype and CYP2D6 inhibitors on tamoxifen","volume":"22","author":"Stearns","year":"2004","journal-title":"Proc Am Soc Clin Oncol"}],"container-title":["Cancer Treatment Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737208002673?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737208002673?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T08:20:54Z","timestamp":1557822054000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0305737208002673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S0305737208002673"],"URL":"https:\/\/doi.org\/10.1016\/j.ctrv.2008.08.001","relation":{},"ISSN":["0305-7372"],"issn-type":[{"value":"0305-7372","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}